Drug Development Program – Quo Vadis? Today it is known that many pharmaceutical companies are investing in their drug development programs not only based on the traditional-classical trial model, but also on adaptive trials in order to reduce time and…
Evaluation and Modeling of 24-hour Profiles of Medical Data Considering the Circadian Rhythm The assessment of such models is performed based on a mixture of both time series analysis and spectral analysis. So for the statisticians, the degree of difficulty…
I offer Clinical Programming and Statistical Support in Clinical Research and Development Phase as well as Post-Marketing Phase across Various Therapeutic Areas
